CellFiber Co., Ltd.
As of January 2024
City | Year of Establishment | Founder |
---|---|---|
Tokyo, Japan | 2015 | Aki Adachi, Shoji Takeuchi, Teru Okitsu, Hiroaki Onoe |
Partner VC | Latest round of Fundraising | Valuation |
---|---|---|
JAFCO Group Co., Ltd. | Series A | Non-Disclosure |
- Contact Information : takahashi.tsubasa@cellfiber.jp
- Website : CellFiber Co., Ltd.
Program name
Deep-Tech Startups Support Program
Research theme
GMP manufacturing of cells with CellFiberTM Technology
Business Plan
While cell therapy has grown in popularity and effectiveness, the manufacturing process still relies heavily on manual labor.
Technology is a technique for encapsulating and culturing cells in hollow hydrogel tubes, which should facilitate large-scale production of cellular products.
Under this project scheme, we aim to implement this technology in GMP environment and confirm effective production of cellular products.
Research Outline
We plan to achieve below items by collaborating with business partners in and out of Japan.
- Develop GMP manufacturing process of CellFiberTM
- Optimize GMP manufacturing process of Investigational New Drug with CellFiberTM technology
- Comply with necessary regulations including GMP for drug cellular products.
- EA, Single-use Kit and Reagent shall comply with GMP
Phase | Business Area/Field | Research Period | Research Grant Amount |
---|---|---|---|
PCA | Healthcare | 2023~2024 FY | JPY 394 million |
Last Updated : August 23, 2024